Moody Lynn & Lieberson LLC Purchases New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Moody Lynn & Lieberson LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 12,014 shares of the biotechnology company's stock, valued at approximately $3,104,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Hardy Reed LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at $231,000. International Assets Investment Management LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at $39,907,000. Arizona State Retirement System grew its stake in shares of Axon Enterprise by 1.9% during the 4th quarter. Arizona State Retirement System now owns 19,520 shares of the biotechnology company's stock valued at $5,043,000 after buying an additional 371 shares during the period. Venturi Wealth Management LLC grew its stake in shares of Axon Enterprise by 4,545.5% during the 4th quarter. Venturi Wealth Management LLC now owns 511 shares of the biotechnology company's stock valued at $132,000 after buying an additional 500 shares during the period. Finally, UMB Bank n.a. lifted its holdings in shares of Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company's stock valued at $115,000 after acquiring an additional 44 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.


Analysts Set New Price Targets

Several research firms recently weighed in on AXON. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $240.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, February 28th. Morgan Stanley lifted their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company an "equal weight" rating in a report on Wednesday, February 28th. StockNews.com lowered shares of Axon Enterprise from a "buy" rating to a "hold" rating in a report on Thursday, March 14th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a "buy" rating in a report on Wednesday, February 28th. Finally, JMP Securities lifted their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a "market outperform" rating in a report on Tuesday, February 6th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $301.73.

Check Out Our Latest Stock Report on Axon Enterprise

Axon Enterprise Stock Up 1.0 %

AXON stock traded up $3.07 during trading on Friday, reaching $309.90. The stock had a trading volume of 183,544 shares, compared to its average volume of 440,078. The company has a market capitalization of $23.39 billion, a P/E ratio of 134.74 and a beta of 0.93. The firm has a fifty day moving average price of $291.26 and a 200 day moving average price of $250.64. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $325.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.29. The business had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, equities analysts anticipate that Axon Enterprise, Inc. will post 2.43 earnings per share for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Axon Enterprise right now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Featured Articles and Offers

Search Headlines: